APA (7th ed.) Citation

Zheng Yan, Kehui Zhang, Ming Ji, Heng Xu, & Xiaoguang Chen. (2021). A Dual PI3K/HDAC Inhibitor Downregulates Oncogenic Pathways in Hematologic Tumors In Vitro and In Vivo. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Zheng Yan, Kehui Zhang, Ming Ji, Heng Xu, and Xiaoguang Chen. A Dual PI3K/HDAC Inhibitor Downregulates Oncogenic Pathways in Hematologic Tumors In Vitro and In Vivo. Frontiers Media S.A., 2021.

MLA (9th ed.) Citation

Zheng Yan, et al. A Dual PI3K/HDAC Inhibitor Downregulates Oncogenic Pathways in Hematologic Tumors In Vitro and In Vivo. Frontiers Media S.A., 2021.